期刊文献+

抗真菌药物的TDM文献计量分析 被引量:1

Bibliometric analysis of research papers in the subject of TDM of antifungal drugs
下载PDF
导出
摘要 目的:全面了解抗真菌药物治疗药物监测的研究进展,为临床合理应用抗真菌药物提供参考,确保患者用药安全。方法:英文检索Pub Med、Embase、Web of Science数据库;中文检索Sino Med关于抗真菌药物的治疗药物监测的文献,检索时间为1985年–2014年。利用End Note X5及人工双重进行分类整理,用Excel表对最终纳入的文献建立评价数据库。分析文献发表的年代、作者、期刊、影响因子、研究机构、被引频次和研究方法,归纳文献涉及抗真菌药物与处理措施。结果:共检索出英文文献359篇,中文29篇。英文数据库检出文献:Pub Med 76篇,Embase 224篇,SCI 59篇;中文数据库检出文献:Sino Med 29篇。经End Note X5和双人手工去除重复文献,按入排标准,最终得到226篇文献。其中,英文文献220篇,中文文献6篇。2004–2014年文献量增加较快,近年来随着抗真菌药物的广泛应用,抗真菌药物的治疗药物监测也逐渐引起重视。纳入研究的文献类型有论著、综述、回顾性分析、病例分析、会议等。结论:由于抗真菌药物在临床应用过程中存在个体差异大和联合用药时易出现不良反应等情况,国内外已对抗真菌药监测加大了关注度。 Objective:To comprehensively understand the research progress of therapeutic drug monitoring (TDM) of antifungal drugs, provide references for clinical rational use of antifungal drugs, and ensure the medication safety of the patients. Methods:PubMed, Embase and Web of Science databases were used for searching English literature; SinoMed was searched for Chinese literature. TDM literature on antifungal drugs were searched from 1985 up to 2014. Endnote X5 and artiifcial double sorting were used, evaluation database based on enrolled literature was established with the Excel. The time of publication, authors, journals, inlfuence factors of published literature, research institutions, the cited frequency and the research methods were analyzed, the antifungal drugs and treatment measures involved in literature were also summarized.Results: A total of 359 English and 29 Chinese articles were retrieved, 76 articles were detected from PubMed, 224 articals from Embase, 59 articals from SCI and 29 articals from SinoMed. And 226 articles were enrolled by removing duplicate documents with EndNote X5 and artiifcial double screening. Among them, 220 articles were English literature, 6 articals were Chinese literature. During 2004–2014, literature volume increased rapidly. With the wide application of antifungal drugs in recent years, TDM of antifungal drugs has attracted more and more attention. The types of these literature included original articles, reviews, retrospective analysis, case analysis, conferences, etc.Conclusion:Due to the individual differences and adverse reactions in clinical application of antifungal drugs, the TDM of antifungal drugs has been paid attention to at home and abroad.
出处 《中国药物应用与监测》 CAS 2015年第3期184-187,共4页 Chinese Journal of Drug Application and Monitoring
基金 十二五国家重大科技专项(2012ZX09303004-002)
关键词 抗真菌药物 治疗药物监测 计量分析 Antifungal drugs Therapeutic drug monitoring (TDM) Bibliometric analysis
  • 相关文献

参考文献15

  • 1Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications[J]. Antimicrob Agents Chemther, 2009, 53(1): 24-34.
  • 2陈丽娟.HPLC测定人血浆中伊曲康唑的浓度[J].华西药学杂志,2006,21(3):293-295. 被引量:10
  • 3史卉妍,彭亮,谭志荣,康桢,何鑫,罗丽芳,吴卫华,阳国平,欧阳冬生.高效液相色谱法测定人血浆中伏立康唑浓度[J].中南药学,2007,5(4):305-308. 被引量:29
  • 4Berl T, Wilner KD, Gardner M, et al. Pharmacokinetics of fluconazole in renal failure[J]. J Am Soc Nephrol, 1995, 6(2): 242-247.
  • 5Pai MP, Turpin RS, Garey KW. Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia[J]. J Antimicrob Chemother, 2007, 51(1): 35-39.
  • 6Denning DW, Tucker RM, Hanson IH. Treatment of invasive aspergillosis with itaconazole[J]. Am J Med, 1989, 86(2): 791- 800.
  • 7Tucker RM, Denning DW, Arathoon EG. Itraconazole therapy for nonmeningeal coccidioidomycoss: clinical and lahoratory observations[J]. J Am Acad Dermatol, 1990, 23(2): 593-601.
  • 8Denning DW, Tucker RM, Hanson LH, et al. Iraconazole therapy for cryptococcal meningitis and cryptococcosis[J]. Arch Intern Med, 1989, 149(10): 2301-2308.
  • 9Trifilio S, Ortiz R, Pennick G, et al. Voriconazole therapcutic drug monitoring in allogeneic hematopoietie stem cell transplant recipients[J]. Bone Marrow Transplant, 2005, 35(5): 509-513.
  • 10Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints[J]. J Clin Microbiol, 2006, 44(3): 819-826.

二级参考文献46

  • 1虞瑞尧.伊曲康唑的药理及其临床应用[J].新药与临床,1989,8(2):88-91. 被引量:2
  • 2南志成.高效液相色谱法测定人血浆中伏立康唑浓度[J].中国医院药学杂志,2006,26(7):836-839. 被引量:16
  • 3[1]Herbrecht R,Denning DW,Patterson TF,et al.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J].N Engl J Med,2002,347(6):408-415.
  • 4[2]Perfect JR,Marr KA,Walsh TJ,et al.Voriconazole treatment for less-common,emerging,or refractory fungal infections[J].Clin Infect Dis,2003,36(9):1122-1131.
  • 5[3]Pfaller MA,Diekema DJ,Rex JH,et al.Correlation of MIC with outcome for Candida species tested against voriconazole:analysis and proposal for interpretive breakpoints[J].J Clin Microbiol,2006,44(3):819-826.
  • 6[4]Theuretzbacher U,Ihle F,Derendorf H.Pharmacokinetic/pharmacodynamic profile of voriconazole[J].Clin Pharmacokinet,2006,45(7):649-663.
  • 7[5]R Hyland,BC Jones,DA Smith.Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole[J].Drug Metab Dispos,2003,31(5):540-547.
  • 8[7]Zhou L,Glickman RD,Chen N,et al.Determination of voriconazole in aqueous humor by liquid chromatography elect rospray ionization-mass spectrometry[J].J Chromatogr B,2002,776(2):213-220.
  • 9[8]Perea S,Pennick GJ,Modak A,et al.Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma[J].Antimicrob Agents Chemother,2004,44(5):1209-1213.
  • 10[10]Luis O-Z,Peter GP.Invasive candidiasis in the intensive care unit[J].Crit Care Med,2006,34 (6):857-863.

共引文献49

同被引文献5

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部